Thomas Looby is President at EKSO BIONICS HOLDINGS, INC. (EKSO). They have made 1 open-market trade across 1 company since 2017, most recently 2017-09-08.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $17K since 2017, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| EKSO | 20,315 | $231K |
Shares reported on the most recent Form 4, priced at the 2017-09-12 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EKSO | BUY | 2017-09-08 | 2017-09-12 | $1.13 | $17K | -1.5% | -9.6% | +100.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.